Followers | 72 |
Posts | 4228 |
Boards Moderated | 2 |
Alias Born | 08/21/2015 |
Saturday, June 16, 2018 1:14:57 AM
https://www.prnewswire.com/news-releases/new-provisional-patents-filed-for-pharmaceutical-cannabidiol-cbd-formulation-consisting-of-ibuprofen--cbd-compounds-aimed-at-treating-pain-289143571.html
Here is another article...
https://www.benzinga.com/trading-ideas/long-ideas/15/02/5244533/5-marijuana-stocks-getting-investors-high-and-7-key-post-lega
The company, which recently switched focus from sugar alternatives to cannabis, has released a series of press relating to the filing of provisional patents for its CBD based pain medication, which is actually a mix of cannabidiol and ibuprofen.
In a January 29 release, George Blankenbaker, President of Stevia Corp stated:
“We believe that there will be significant advantages of using these four very effective drugs in combination with cannabidiol as opposed to using these drugs alone. Acetaminophen, Ibuprofen, Naproxen and Aspirin generate billions of dollars in sales each year. Our four provisional patent applications include 63 claims in total and we look forward to filing the utility patents over the next 12 months. We strongly believe that our intellectual property strategy, if successfully implemented, will provide us a competitive advantage over other healthcare companies using cannabinoids for human healthcare.”
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM